To meet growing demand for its services LOG, an Israeli pharma primary packaging converter specialising in oxygen and moisture barrier solutions, is significantly expanding its manufacturing floor to increase capacity.
The expansion includes the construction of a multi-million-dollar ISO 8 cleanroom that the company claims will bring productivity benefits to its blue-chip customers, which include Unilever, Teva, Chemo and Gedeon Richter. It also includes the installation of automated online inspection and artificial intelligence surveillance.
The 600 sq m factory floor expansion is currently underway and on schedule for completion by August 2022.
Shaul Bassi, LOG’s chief executive Officer, said the company – which also has a manufacturing site in Hungary – is seeing rapid growth for its packaging solutions for pharmaceutical companies worldwide. The company has developed a number of solutions to extend shelf life and protect generic drugs from exposure to moisture and/or oxygen. Made from up to six layers, LOG’s barrier packaging solutions are available for liquids and solids, and come in standard sizes from 15ml to 1.5-litre and with neck finishes between SP20 and SP53.
The company utilises a range of blow moulding technology, including extrusion blow moulding (EBM), injection blow moulding (IBM), injection stretch blow moulding (ISBM) and CoEx-EBM. LOG also leverages injection and other technologies, as well as providing designated printing areas, desiccant filling and assembly services.


